Stijn Hentzen

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Systematic Review

Top Venues

Journal of medical cases

Exploration of targeted anti-tumor therapy

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Khalil Choucair, Caroline Nebhan, Alessio Cortellini, Stijn Hentzen, Yinghong Wang, Cynthia Liu, Raffaele Giusti, Marco Filetti, Paolo Antonio Ascierto, Vito Vanella, Domenico Galetta, Annamaria Catino, Nour Al-Bzour, Azhar Saeed, Ludimila Cavalcante, Pamela Pizzutilo, Carlo Genova, Melissa Bersanelli, Sebastiano Buti, Douglas B Johnson, Claudia Angela Maria Fulgenzi, David James Pinato, Maluki Radford, Chul Kim, Abdul Rafeh Naqash, Anwaar Saeed
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival. Cancers 15 (20) (2023)
Stijn Hentzen, Kathan Mehta, Raed Moh'd Taiseer Al-Rajabi, Anwaar Saeed, Joaquina Celebre Baranda, Stephen K Williamson, Weijing Sun, Anup Kasi Loknath Kumar
Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy. Exploration of targeted anti-tumor therapy 4 (3) (2023)
Stijn Hentzen, Tomer Meirson, Kelly Koehn, Aaron Goodman, Rajshekhar Chakraborty, Douglas Sborov, Samuel Rubinstein, Ghulam Rehman Mohyuddin
Attrition and withdrawal in multiple myeloma randomized controlled trials: A systematic review. European journal of haematology (2023)
Anup Kasi, Stijn Hentzen, Nikhil Gupta, Padma Poddutoori, Rashna Madan, Shrikant Anant, Sufi Mary Thomas
Immunoglobin A Deficiency and Squamous Cell Carcinoma With a Rare Presentation as Anal Cancer. Journal of medical cases 13 (1) (2022)
Aviva Atri-Schuller, Hassan Mohammed Abushukair, Ludimila Cavalcante, Stijn Hentzen, Azhar Saeed, Anwaar Saeed
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer. Current issues in molecular biology 44 (11) (2022)